Zenrelia (Ilunocitinib Tablet) 6.4 mg, 30 Count

Zenrelia (Ilunocitinib Tablet) 6.4 mg, 30 Count removed from the wishlist

Zenrelia (Ilunocitinib Tablet) 6.4 mg, 30 Count


Prescription item 11
Prescription Item
This item requires prescription approval




Free Shipping $35+
Icon carat down

Description

Please note that the product information displayed is provided by manufacturers, suppliers and other third parties and is not independently verified by Petco.

Zenrelia (ilunocitinib tablets) is a prescription itch relief medication for dogs that relieves itching due to allergic dermatitis and controls atopic dermatitis. The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making them feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog's vaccine schedule with your veterinarian. **Clinical remission of itch demonstrated by a Normal-PVAS<2

  • - Zenrelia relieves itching in dogs due to allergic dermatitis and controls atopic dermatitis
  • - Zenrelia works fast, providing visible improvements in itch* * Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology. 2025; 1-10
  • - Ilunocitinib, the active ingredient in Zenrelia, works by reducing the itch and inflammatory response in your dog's skin due to allergies
  • - The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert including the Boxed Warning
  • - The once-daily tablet can be given with or without food from the comfort of your home

Specifications

SKU4608945
Primary BrandZenrelia
Days to ShipShips Next Business Day

Additional Features

Personalized Item flagNo

Once daily, oral tablet for the control of itch associated with allergic and atopic dermatitis, in dogs 12 months and up.

VACCINE-INDUCED DISEASE AND INADEQUATE IMMUNE PRESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of fatal vaccine-induced disease from modified live virus vaccines and inadequate immune response to any vaccine. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination (see Warnings and Target Animal Safety). See package insert including the Boxed Warning. For full prescribing information speak with your veterinarian, call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia.

Reviews

Review this Product

Adding a review will require a valid email for verification

Questions

Styled arrow button